ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 336

$1.24M Total Retail Price of All Prescriptions

Rank: 17 out of 336

834 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 19,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 950 810 1 1
HYDROCODONE-ACETAMINOPHEN 932 633 S3 2 2
OMEPRAZOLE 787 641 3 3
SIMVASTATIN 733 564 4 5
LEVOTHYROXINE SODIUM 703 544 5 7
LISINOPRIL 674 516 6 6
METFORMIN HCL 559 417 7 8
POTASSIUM CHLORIDE 552 418 8 9
PRAVASTATIN SODIUM 508 348 9 10
METOPROLOL SUCCINATE 491 403 10 15
ZOLPIDEM TARTRATE 489 396 11 18
FUROSEMIDE 484 413 12 4
GABAPENTIN 458 286 13 11
HYDROCHLOROTHIAZIDE 440 322 14 12
LOSARTAN POTASSIUM 419 352 15 22
CARVEDILOL 332 293 16 13
SERTRALINE HCL 332 252 16 33
GLIMEPIRIDE 330 253 18 29
TRAMADOL HCL 295 226 19 20
METFORMIN HCL ER 284 200 20 61
CRESTOR 262 211 21 25
MELOXICAM 245 159 22 19
ATORVASTATIN CALCIUM 243 192 23 14
PANTOPRAZOLE SODIUM 243 182 23 40
ALENDRONATE SODIUM 236 192 25 54
LOSARTAN-HYDROCHLOROTHIAZIDE 227 202 26 45
INDAPAMIDE 222 189 27 160
KLOR-CON M20 214 165 28 51
CITALOPRAM HBR 214 165 28 21
ISOSORBIDE MONONITRATE ER 214 212 28 44
WARFARIN SODIUM 208 189 31 17
TRAZODONE HCL 206 168 32 46
LANTUS 204 122 33 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 178 34 23
SYNTHROID 198 163 35 43
NEXIUM 197 106 36 24
RANITIDINE HCL 187 161 37 36
CYMBALTA 185 86 38 52
CHLORTHALIDONE 180 156 39 111
FLUOXETINE HCL 173 101 40 81
ALLOPURINOL 166 142 41 30
DIOVAN 159 132 42 31
METOPROLOL TARTRATE 159 118 42 16
ENALAPRIL MALEATE 156 127 44 60
LEVOXYL 153 124 45 180
SPIRONOLACTONE 147 131 46 42
CLOPIDOGREL 147 120 46 28
TAMSULOSIN HCL 145 112 48 38
LOVASTATIN 142 100 49 34
TRIAMTERENE-HCTZ 142 112 49 35
POLYETHYLENE GLYCOL 3350 141 108 51 68
CYCLOBENZAPRINE HCL 139 63 R 52 65
MIRTAZAPINE 131 77 53 66
ATENOLOL 129 98 54 26
FELODIPINE ER 128 123 55 171
PLAVIX 123 100 56 37
DONEPEZIL HCL 118 117 57 27
FLUTICASONE PROPIONATE 112 76 58 49
DOXAZOSIN MESYLATE 111 97 59 86
LEVOFLOXACIN 111 80 59 93
FINASTERIDE 107 107 61 156
CLONIDINE HCL 106 76 62 32
DIGOXIN 106 106 62 50
ACTOS 103 82 64 119
TORSEMIDE 103 101 64 127
DIOVAN HCT 97 85 66 41
INSULIN SYRINGE 96 66 67 102
AMITRIPTYLINE HCL 94 69 R 68 57
AZITHROMYCIN 93 74 69 58
LIPITOR 90 79 70 62
CELEBREX 90 62 70 105
FENOFIBRATE 89 55 72 72
LANTUS SOLOSTAR 86 61 73 124
BUSPIRONE HCL 84 51 74 113
CIPROFLOXACIN HCL 84 66 74 55
PAROXETINE HCL 84 84 74 64
METHYLPREDNISOLONE 84 69 74 104
FENTANYL 83 45 S2 78 120
KLOR-CON 10 82 70 79 75
JANUVIA 82 65 79 67
MORPHINE SULFATE ER 78 29 S2 81 182
PREDNISONE 77 50 82 48
AMLODIPINE BESYLATE-BENAZEPRIL 73 65 83 47
QUINAPRIL HCL 73 58 83 107
LYRICA 73 41 83 70
VERAPAMIL ER 71 56 86 95
ADVAIR DISKUS 67 52 87 82
PROPRANOLOL HCL 66 45 88 101
DOXYCYCLINE HYCLATE 65 56 89 92
TRICOR 62 28 90 108
PROAIR HFA 62 24 90 77
NAMENDA 60 60 92 39
LANSOPRAZOLE 60 36 92 167
METOCLOPRAMIDE HCL 60 30 92 123
TIZANIDINE HCL 59 28 95 83
CILOSTAZOL 58 53 96 158
CARISOPRODOL 58 17 R 96 63
PEN NEEDLE 57 28 98 162
FAMOTIDINE 56 51 99 73
MECLIZINE HCL 56 43 99 96
LEVETIRACETAM 54 49 101 114
GLYBURIDE 54 54 R 101 76
BUPROPION HCL SR 54 17 101 199
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 45 104 164
PROMETHAZINE HCL 52 16 R 105 99
SINGULAIR 51 43 106 85
ZETIA 51 42 106 74
VENLAFAXINE HCL ER 51 32 106 100
OXYBUTYNIN CHLORIDE 50 32 109 153
WELCHOL 50 38 109 195
HUMULIN 70-30 50 44 109 173
ESTRADIOL 50 49 R 109 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.